Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Nature Reviews Nephrology

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrneph.2011.74PMID 21712851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cited by this paper
• CORRIGENDUM: Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cited by this paper
• Expressing thiopurine S-methyltransferase activity as units per litre of whole-blood overcomes misleading high results in patients with anaemia

  2010cited by this paper
• TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients

  2009cited by this paper
• Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes to 6-MP related toxicities in childhood ALL patients

  2009cited by this paper
• Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

  2009cited by this paper
• Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis.

  2006cited by this paper
• Prevalence of Methylenetetrahydrofolate Reductase Polymorphisms in Young Patients with Inflammatory Bowel Disease

  2006cited by this paper
• Thiopurine Therapies: Problems, Complexities, and Progress With Monitoring Thioguanine Nucleotides

  2005cited by this paper
• Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation

  2005cited by this paper
• Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells

  2005cited by this paper
• TPMT genotype screening for patients about to begin azathioprine treatment--a look at costs and potential benefits.

  2005cited by this paper
• Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.

  2004cited by this paper
• Consequences of binding an S-adenosylmethionine analogue on the structure and dynamics of the thiopurine methyltransferase protein backbone.

  2004cited by this paper
• Mistaken identity: misclassification of TPMT phenotype following blood transfusion.

  2003cited by this paper
• Appendicectomy and ulcerative colitis

  2003cited by this paper
• Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis.

  2002cited by this paper
• Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.

  2001cited by this paper
• Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

  2000cited by this paper
• Recombinant human granulocyte colony-stimulating factor after kidney transplantation: a retrospective analysis to evaluate the benefit or risk of immunostimulation.

  2000cited by this paper
• Thiopurine methyltransferase polymorphic tandem repeat: Genotype‐phenotype correlation analysis

  2000cited by this paper
• Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.

  1999cited by this paper
• Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms

  1997cited by this paper
• Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance

  1997cited by this paper
• The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine.

  1993cited by this paper
• Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.

  1993cited by this paper
• The Pharmacology of Azathioprine

  1993cited by this paper
• THE IMPORTANCE OF THIOPURINE METHYLTRANSFERASE ACTIVITY FOR THE USE OF AZATHIOPRINE IN TRANSPLANT RECIPIENTS1

  1992cited by this paper
• Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant Patients

  1990cited by this paper
• Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6‐thioguanine nucleotide concentrations

  1987cited by this paper
• Studies on the mechanism of formation of 5-mercapto-1-methyl-4-nitroimidazole, a metabolite of the immunosuppressive drug azathioprine.

  1974cited by this paper
• Hazard of combining allopurinol and thiopurine.

  1972cited by this paper

• Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products.

  2024cites this paper
• Azathioprine Induced Pancytopenia with Pneumonia and Sepsis: A Rare and Potentially Fatal Occurence with Dermatologic Use

  2023cites this paper
• Azathioprine‐induced pancytopenia: A case report

  2022cites this paper
• An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice

  2022cites this paper
• Implementation of NUDT15 Genotyping to Prevent Azathioprine‐Induced Leukopenia for Patients With Autoimmune Disorders in Chinese Population

  2022cites this paper
• Predictive Model of Chemotherapy-Induced Myelosuppression for Patients with Esophageal Cancer

  2021cites this paper
• A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease

  2021cites this paper
• Reducing risk in thiopurine therapy

  2020cites this paper
• Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians

  2018cites this paper
• Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan

  2018cites this paper
• Azathioprine-induced pancytopenia with normal TPMT activity presenting with HSV oral ulcers

  2018cites this paper
• Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update

  2018cites this paper
• Pharmacokinetics and Genomics of Immunosuppressive Drugs

  2017cites this paper
• Pharmacogenomics in Pediatric Oncology: Review of Gene—Drug Associations for Clinical Use

  2016cites this paper
• Analysis of Thiopurine S-Methyltransferase Deficient Alleles in Acute Lymphoblastic Leukemia Patients in Mexican Patients.

  2016cites this paper
• Genetics and nonmelanoma skin cancer in kidney transplant recipients.

  2015cites this paper
• Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

  2015cites this paper
• Erratum to: Pharmacologic Targeting of Regulatory T Cells for Solid Organ Transplantation: Current and Future Prospects

  2015cites this paper
• Pharmacogenetics and immunosuppressive drugs in solid organ transplantation

  2014cites this paper
• Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs

  2014cites this paper
• Drugs that act on the immune system

  2014cites this paper
• Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients

  2014cites this paper
• The argument for the use of mizoribine in renal transplantation: a meta-analysis and systemic review.

  2013cites this paper
• Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia

  2013cites this paper
• Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

  2013cites this paper